echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Pfizer and AZ topped the list, and Baekje entered the top 10!

    Pfizer and AZ topped the list, and Baekje entered the top 10!

    • Last Update: 2022-06-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 22, IDEA Pharma released the global pharmaceutical innovation and invention index list, Pfizer and AZ ranked first in the two lists respectively; BeiGene and Takeda became the two companies that rose the most; BioNTech, UCB, Horizon, Shionogi is this year's newcomer


    "If the same molecule was given to two pharmaceutical companies at an early stage, would they have had the same success?"

    IDEA Pharma's answer is no, the answer is obvious, but the reasons behind it are even more intriguing


    In this year's list, Pfizer topped the list, while Eli Lilly, which was No.


    01.


    01.


    02.


    02.


    03.


    03.


    Shionogi has been established for more than 100 years.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.